Among postmenopausal women using vaginal estrogens, the risk of cardiovascular disease (CVD) and cancer were not elevated, a recent study found. The prospective observational cohort study included 45,663 participants (aged 50 to 79 years at baseline) from the Women’s Health Initiative Observational Study who did not use systemic estrogen therapy during 7.2 years’ follow-up. Data were analyzed on incident coronary heart disease (CHD), invasive breast cancer, stroke, pulmonary embolism, hip fracture, colorectal cancer, endometrial cancer, death, and self-reported use of vaginal estrogen. Researchers found:
- The risk of stroke, invasive breast cancer, colorectal cancer, endometrial cancer, and pulmonary embolism/deep vein thrombosis were not significantly different between vaginal estrogen users and nonusers.
- However, the risk of CHD, fracture, all-cause mortality, and global index event (GIE) were lower in users than in nonusers (GIE adjusted HR, 0.68).
- Among women who had a hysterectomy, the risk of each individual GIE components and of the overall GIE were not significantly different in users vs nonusers.
Crandall CJ, Hovey KM, Andrews CA, et al. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women’s Health Initiative Observational Study. [Published online ahead of print August 14, 2017]. Menopause. doi:10.1097/GME.0000000000000956.
This Week's Must Reads
ACOG Discourages Direct-to-Consumer Genetic Testing, Obstet Gynecol; ePub 2017 Nov; ACOG
Interpregnancy Interval After Pregnancy Loss, Obstet Gynecol; ePub 2017 Nov 3; Sundermann, et al
Opioid Prescribing & Patient Use After Hysterectomy, Obstet Gynecol; ePub 2017 Nov 3; As-Sanie, et al
IUD Retention After Cesarean or Vaginal Delivery, Contraception; ePub 2017 Nov 8; Colwill, et al
Discontinuation of Oral HT & Sexual Activity, Menopause; ePub 2017 Nov 6; Gass, et al
Must Reads in Breast Cancer
Black-White Disparities in Breast Cancer Survival, J Clin Oncol; ePub 2017 Oct 16; Jemal, et al
Mammography Screening Patterns Evaluated, Womens Health Issues; ePub 2017 Sep 18; Jacobson, et al
FDA Approves New Mammography Device, FDA news release; 2017 Sep 1
Reducing the Risk of Hereditary Breast & Ovarian Ca, Obstet Gynecol; 2017 Sep; ACOG Comm on Pract Bulletins
CVD & Ca Risk in Women Using Vaginal Estrogen, Menopause; ePub 2017 Aug 14; Crandall, et al